Concepedia

Ian McAlexander

IM

6

Publications

264

Citations

6

H-Index

2002

Active since

Affiliations

Bayer (United States)(Current)

Ian McAlexander is an author at Bayer (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2002–2011

6

Publications

6

Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1

Keith D. Tardif, Aaron Rogers, Jared Cassiano et al. · Molecular Cancer Therapeutics · 2011 · 93 citations · Full text

, , +17

Deployment of a Carbon Isotope Ratiometer for the Monitoring of CO<sub>2</sub> Sequestration Leakage

Ian McAlexander, Greg H. Rau, J. Liem et al. · Analytical Chemistry · 2011 · 45 citations

, , +16

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors

Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

, , +5

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate

Jill E. Wood, Cedo M. Bagi, Christiana Akuche et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 28 citations · Full text

, , +8

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 2. SAR

David Gunn, Christiana Akuche, Jeremy L. Baryza et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 28 citations · Full text

, , +10

Rows per page

1–5 of 6